Home › added
 

Keywords :   


Tag: added

Ask.com Crapware Added to Mac OS X Java Installations

2015-03-07 00:02:19| PC Magazine Security Product Guide

Spoiler: Don't just blindly click through prompts when installing Java, or else you'll get a little surprise, too.

Tags: added mac java installations

 

Ask.com Crapware Added to Mac OS X Java Installations

2015-03-06 22:03:31| PC Magazine Software Product Guide

Spoiler: Don't just blindly click through prompts when installing Java, or else you'll get a little surprise, too.

Tags: added mac java installations

 
 

Top US pay TV operators added 101,000 subscribers in 4Q14

2015-03-05 18:30:37| Digital TV News

The top Pay TV Operators in the United States added 101,000 new subscribers during the fourth quarter, according to Strategy Analytics. The declining trend in Pay TV subscribers in North America, seen during the second and third quarters, reversed in the fourth quarter.

Tags: top added pay operators

 

STLD Added as Top 5 Metals Channel Dividend Stock With 2.50% Yield

2015-03-05 17:21:44| Steel - Topix.net

We work to find the most relevant and interesting articles about yield stocks to share with Forbes readers. The site is a one-stop source for aggregated data on dividend stocks, including features such as a dividend stock screener, a live dividend feed, an ex-div calendar, and a dividend calculator.

Tags: top added stock channel

 

Two New Post-Hoc Analyses of TRA 2°P TIMI 50 Study Showed ZONTIVITY (vorapaxar) Added to Aspirin and/or Clopidogrel Reduced Acute Limb Ischemia and Peripheral Revascularizations, Respectively, in Certain Patients with Peripheral Arterial Disease

2015-03-05 14:00:00| Merck.com - Product News

Dateline City: KENILWORTH, N.J. These and other post-hoc subgroup analyses from TRA-2°P are being presented at the 2015 American College of Cardiology Scientific Sessions KENILWORTH, N.J.--(BUSINESS WIRE)--Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced results from two post-hoc analyses of the TRA 2°P TIMI 50 (Thrombin Receptor Antagonist in Secondary Prevention of Atherothrombotic Ischemic Events) trial of ZONTIVITY (vorapaxar), one of the largest secondary prevention studies of an antiplatelet medicine. Language: English Contact: MerckMedia:Pamela Eisele, 267-305-3558orMichael Close, 267-305-1211orInvestors:Justin Holko, 908-740-1879 Ticker Slug: Ticker: MRK Exchange: NYSE read more

Tags: with added study reduced

 

Sites : [36] [37] [38] [39] [40] [41] [42] [43] [44] [45] [46] [47] [48] [49] [50] [51] [52] [53] [54] [55] next »